Johnson & Johnson said it agreed to pay $8.9 billion to resolve all cancer lawsuits tied to its talc-based powders and will make a fresh attempt to contain the liability within a bankruptcy filing by one of its units.
Related posts:
Ancient Aliens ‘The Reptilians’
The superfood power of goji berries
Top Cancer Expert: Aggressive Cancers Appearing After Vaccine Boosters 'Not a Coincidence'
The billion-dollar motorway leading Montenegro to nowhere
Cancer among 9/11 workers sparks political storm
The “Deadly Breast Cancer Gene” is a Myth, Lancet Study Confirms